Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ask Vendit Off-Topic Questions -- Ignore unavailable to you. Want to Upgrade?

To: Jill who wrote (4561)	2/3/2005 12:42:57 AM
From: Walkingshadow	Read Replies (1) \| Respond to of 8752

I have no idea what GERN's story is.... I rarely trade anything based on a story. I have had too much experience watching great stories get ignored or crucified by the market, especially in the biotech sector. Brilliant science often does not translate into higher stock prices. There are exceptions, but only when I think the stock may be on the mo-mo hit list. A few recent examples of that included STEM and SPDV. The mo-mo crowd tends to return periodically to some stocks to feed some more, and I think both of these fall into that category. 139.142.147.218 139.142.147.218 Walkingshadow is from Macbeth: To-morrow, and to-morrow, and to-morrow, Creeps in this petty pace from day to day To the last syllable of recorded time, And all our yesterdays have lighted fools The way to dusty death. Out, out, brief candle! Life's but a walking shadow, a poor player That struts and frets his hour upon the stage And then is heard no more: it is a tale Told by an idiot, full of sound and fury, Signifying nothing. [Act V, Scene 5:17-28] Shakespeare evidently took the metaphorical image from Solomon: Solomon 2.4: "Our life shall pass away as the trace of a cloud, and come to nought as the mist that is driven away with the beams of the sun. For our time is as a shadow that passeth away and after our end there is no returning." T/WS